Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luole capsule as adjunctive therapy for primary liver cancer (Qi deficiency and blood stasis pattern)
CTR20131928Phase 2Active
- Sponsor
- Shandong University of Traditional Chinese Medicine
- Start
- Jan 2014
- Countries
- 1
01
Overview
A Phase 2 trial of Luole capsule in hepatocellular carcinoma (HCC), sponsored by Shandong University of Traditional Chinese Medicine. Started Jan 2014; status: active.
02
Drugs
Luole capsule
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on CTR20131928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131928.